Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00514722 · ClinicalTrials.gov registry record · NA
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00514722 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 4 participants.
The verdict
NCT00514722, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a pilot study designed to evaluate the safety and feasibility of performing umbilical cord blood transplants in adults with high-risk hematopoietic malignancies. A novel myeloablative preparative regimen will be used. One, up to a maximum of three cord blood units will be administered to facilitate engraftment.
Interventions
- OTHER umbilical cord stem cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2002-10 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00514722
The ClinicalTrials.gov registry entry for NCT00514722 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which umbilical cord stem cells is the first listed.
NCT00514722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00514722 about?
NCT00514722 is a clinical study titled "Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies". This is a pilot study designed to evaluate the safety and feasibility of performing umbilical cord blood transplants in adults with high-risk hematopoietic malignancies. A novel myeloablative preparative regimen will be used. One, up to a maximum of three cord blood units will be administered to fac...
What is the current status of trial NCT00514722?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2002-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00514722?
The interventions under investigation include: umbilical cord stem cells (OTHER).
Who is sponsoring clinical trial NCT00514722?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.